Module 2 gout Flashcards

1
Q

Gout patho

A

alteration in purine metabolism resulting in hyperuricemia and deposition of urate crystals in tissues

  • 30-50 y/o
  • men > women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

gout s/s

A

sudden pain
erythema
limited range of motion
swelling in joint

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

primary gout

A

defect in purine metabolism and or uric acid excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

secondary gout

A

r/t

  • cancer
  • CRF
  • drugs
    • salicylates, antineoplastics, diuretics, ethambutol, nicotinic acid, cyclosporin, ethanol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gout pharmacological pain tx

A

NSAID

corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antigout medication

A

colchicine
allopurinol
febuxastat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

uricosuric agents

A

probenecid

sulfinpyrazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

colchicine MOA

A

disruption of urate deposition and subsequent inflammatory reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Colchicine use

A

acute gout attack

prophylaxis with chronic gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

colchicine AE

A

adb. pain

N/V/D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

colchicine interactions

A

cyclosporine
tacrolimus
verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

colchicine administration

A

acute attack:
- 1.2mg x 1, 0.6-1.2mg q1-2hr till relief of diarrhea

Maintenance:

  • < 1 attack/year: 0.6mg 3-4x/week
  • > 1 attack/year: 0.6-1.2mg/day
  • serious case: 1.2-1.8mg/day

No effect on uric acid levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

probenecid use

A

uricosuric agent
prophylactic gout tx
prevention of disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

probenecid MOA

A

dec. urate reabsorption in PCT

non-selective blockade of active renal transport of organic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

probenecid AE

A

hypersensitivity
GI upset
Urate kidney stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

probenecid precaustions

A
do not start during acute attack
inc. attacks may occur with first 6-12mo 
to minimize risk of urate kidney stones
- inc. fluids, min. of 2L/day
- alkaline urine: NaHCO3
17
Q

probenecid interactions

A

penicillin

naproxen

18
Q

allopurinol MOA

A

antigout
inhibits uric acid production
- Prodrug: converted by xanthine oxidase

19
Q

allopurinol interactions

A

azathioprine: 6-metcaptopurine toxicity

20
Q

allopurinol education

A

as uric acid levels dec
-> dissolution of deposits
-> acute attacks
Can take with colchicine

21
Q

febuxostat MOA

A

antigout
inhibits xanthine oxidase
- prevents uric acid production

22
Q

febuxostat AE

A

elevated LFT

23
Q

febuxostat precautions

A

inc. risk gouty attacks with tx initiation

- take with NSAID or Colchicine

24
Q

sulfinpyrazone MOA

A

inhibit renal tubular reabsorption of urate and thus inc. renal excretion

25
sulfinpyrazone use
gout | - when probenecid and allopurinol are not tolerated
26
sulfinpyrazone AE
GI upset | - take with food
27
sulfinpyrazone contraindications
sulfa allergy | avoid aspirin
28
asymptomatic hyperuricemia features
plasma urate: > 6.0 mg/dL in women > 7.0 mg/dL in men
29
acute gout features
acute arthritis typically metatarsophalangeal joints excruciating pain
30
acute gout Rx
NSAID colcichine glucocorticoids
31
intercritical phase features
asymptomatic hyperuricemia | 10% may never have another attack
32
intercritical phase Rx
none
33
chronic gout features
hyperuricemia development of tophi recurrent attacks of acute gout
34
chronic gout Rx
allopurinal probenecid sulfinpyrazone